November 14-15, 2022 | Washington, DC 


Learn about the latest technologies, partnerships and advances propelling the field of repurposing and re-shaping drug discovery and development


2017 Conference Chairs and Speaking Faculty


Conference Chairs

Bruce Bloom

President & Chief Science Officer
Cures Within Reach


Aris Persidis, Ph.D.



Speaking Faculty

  • Ron Alfa, MD, Ph.D.

  • Vice President, Discovery and Product
  • Recursion Pharmaceuticals

  • Bobbie Ann Austin, Ph.D.

  • Program Officer, Drug Development Partnership Programs, NCATS, Office of the Director
  • National Institutes of Health

  • Paul Bogdan, Ph.D.

  • Assistant Professor, Department of Electrical Engineering
  • University of Southern California

  • Pieter Dylst

  • Senior Manager Market Access and Value Added Medicines
  • Medicines for Europe

  • Rodolphe Hajj, Ph.D.

  • Chief Pharmacology Officer
  • PharNext SA

  • Laura Kleiman, Ph.D.

  • Executive Director
  • Cures Within Reach for Cancer

  • Daphna Laifenfeld, Ph.D.

  • Senior Director, Personalized and Predictive Medicine
  • Teva Pharmaceutical Industries

  • Kevin Pan, Ph.D.

  • Chief Executive Officer
  • Asieris Pharmaceuticals

  • Xavier Paoli

  • CCO and VP of R&D Operations
  • PharNext SA

  • Michael Pollastri, Ph.D.

  • Associate Professor & Chair
  • Northeastern University, College of Science

  • Lieven Lagae, MD, Ph.D.

  • Professor, Paediatric Neurology
  • Katholieke Universiteit Leuven

  • Vidula Sukhatme

  • Founder & CEO
  • Global Cures

  • Berish Y. Rubin, Ph.D.

  • Professor, Department of Biological Sciences
  • Fordham University

  • Robert Lavieri, Ph.D.

  • Project Manager, Vanderbilt Institute for Clinical and Translational Research
  • Vanderbilt University Medical University

  • Michael Tranfaglia, MD

  • Medical Director, Chief Scientific Officer
  • FRAXA Research Foundation

  • Gregory Stewart, Ph.D.

  • Chief Scientific Officer
  • Pairnomix


  • Chad Nivens, Ph.D.

  • Director, Translational Science, Innovative Medicines & Early Development Biotech Unit
  • AstraZeneca Pharmaceutical LP

  • Clare Thibodeaux, Ph.D.

  • Director of Scientific Affairs
  • Cures Within Reach

  • Scott Weir, Pharm.D., Ph.D.

  • Frank B. Tyler Cancer Research Professor in Therapeutic Discovery, Director, Institute for Advancing Medical Innovation, Associate Director – Translational Research
  • University of Kansas, University of Kansas Cancer Center

  • Hermann Mucke, Ph.D.

  • Principal
  • H.M. Pharma Consultancy

  • Maria Shkrob Ph.D.

  • Professional Services Consultant
  • Elsevier

  • Sharlene Velichko, Ph.D.

  • Director of Research Biology
  • DiscoverX

  • Andrew Reaume, Ph.D., MBA

  • President and CEO
  • Melior Discovery

  • Nandu Gattu, Ph.D.

  • Vice President, Pharma Analytics
  • Excelra

  • Ya'ara Goldschmidt, M.Sc, Ph.D.

  • Manager, Machine Learning and Data Mining Group
  • IBM

  • Gregory Koytiger, Ph.D.

  • Associate Director, Translational Research
  • Immuneering Corporation

Contact Us

Arrowhead Publishers
PO Box 96
Chanhassen, MN 55317


About Us

Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward.